Abstract. Detection and enumeration of circulating cells in the bloodstream of small animals are important in many areas of preclinical biomedical research, including cancer metastasis, immunology, and reproductive medicine. Optical in vivo flow cytometry (IVFC) represents a class of technologies that allow noninvasive and continuous enumeration of circulating cells without drawing blood samples. We recently developed a technique termed computer vision in vivo flow cytometry (CV-IVFC) that uses a high-sensitivity fluorescence camera and an automated computer vision algorithm to interrogate relatively large circulating blood volumes in the ear of a mouse. We detected circulating cells at concentrations as low as 20 cells∕mL. In the present work, we characterized the performance of CV-IVFC with low-contrast imaging conditions with (1) weak cell fluorescent labeling using cell-simulating fluorescent microspheres with varying brightness and (2) high background tissue autofluorescence by varying autofluorescence properties of optical phantoms. Our analysis indicates that CV-IVFC can robustly track and enumerate circulating cells with at least 50% sensitivity even in conditions with two orders of magnitude degraded contrast than our previous in vivo work. These results support the significant potential utility of CV-IVFC in a wide range of in vivo biological models.
Introduction
There are many areas of biomedical research where detection and enumeration of rare circulating cells in the bloodstream of small animals are important, including cancer metastasis, hematological malignancies, immunology, and reproductive medicine. [1] [2] [3] [4] [5] [6] [7] The classical method for enumerating circulating cells is to draw small peripheral blood (PB) samples from the animals, which are subsequently analyzed with techniques such as flow cytometry, fluorescence microscopy, or more recently with microfluidic devices. [8] [9] [10] [11] [12] However, this "ex-vivo" approach is known to be fundamentally problematic, since handling, storage, and enrichment of PB samples have been shown to affect cell viability and behavior. [13] [14] [15] [16] These limitations motivated the development of "in vivo flow cytometry" (IVFC) technology by Lin et al. in 2004, 17,18 wherein circulating cells are optically counted without the need for drawing blood samples. Briefly, in IVFC, a laser slit illuminates a small blood vessel in the ear or retina of a mouse. As fluorescently labeled cells pass through the field of view (FOV), fluorescent "spikes" are detected by the instrument. As such, circulating cells can be noninvasively and continuously counted in vivo allowing, for example, detection of rapid changes in circulating cell populations over time in response to drug treatment. [19] [20] [21] Other IVFC variants have also been developed, including multiphoton IVFC, photo-acoustic flow cytometry, and photo-thermal flow cytometry. [22] [23] [24] [25] [26] [27] [28] [29] [30] IVFC has been used for the in vivo study of many cell types, including breast cancer, prostate cancer, hepatocellular carcinoma cells, melanoma, multiple myeloma, T-lymphocytes, infections, and sickle cells. 18, 21, 22, [28] [29] [30] [31] [32] [33] [34] [35] [36] Despite its great utility in small animal research, IVFC has one significant limitation: the relatively low cell detection sensitivity, which is a consequence of the small blood vessels that are sampled. Specifically, blood flow rates in an ear arteriole are on the order of 1 μL∕ min, whereas a mouse has approximately 2 mL of circulating blood. Therefore, in a 15-min scan, only about 1% of the total circulating blood volume is sampled, so that low-abundance cell types may be entirely missed. Motivated by this limitation, our group (and others 31, 32 ) has developed new IVFC approaches that interrogate larger circulating blood volumes and, therefore, increase detection sensitivity. [37] [38] [39] [40] [41] Most relevant to the present work, we recently developed and validated a technique termed Computer Vision IVFC (CV-IVFC). 40 Briefly, we developed an instrument that utilizes macroscopic fluorescence imaging of a relatively large (5 × 5 mm 2 ) region of a mouse ear, where circulating blood volumes are on the order of 10-15 μL∕ min, i.e., an order of magnitude greater than microscopy-IVFC. The imager used a red (660 nm) excitation laser and a filtered high-sensitivity electron multiplied charge-coupled device (EMCCD) camera that acquired fluorescence images with a 19 Hz frame rate. As fluorescently labeled circulating cells passed through the ear, they were detected by the camera. We also developed an algorithm to automatically detect and track circulating cells from the image sequences. This was necessary for three reasons: (1) the rarity of the low-abundance cells that we were studying (i.e., the infrequency of arrival in the instrument FOV), (2) the large FOV (relative to cell size), and (3) the relatively large background autofluorescence and camera noise. We validated CV-IVFC, first in flow-phantom models with calibrated microspheres, and second in mice with injected multiple myeloma (MM) cells labeled with the vybrant-DiD near-infrared fluorescent dye. We demonstrated that CV-IVFC was capable of detecting and tracking circulating cells at concentrations of 20 cells∕mL of circulating blood volume in a 30-min scan. This is potentially extremely valuable for applications involving rare circulating cells; for example, in measurement of the dissemination of circulating tumor cells in animal models of cancer metastasis where typical cell concentrations are on the order of 1-100 cells∕mL. Moreover, unlike microscopy IVFC, CV-IVFC allows visualization of in vivo cell behavior of interest such as homing and docking events in the vasculature.
While our previous work demonstrated proof of principle of the approach, the performance of CV-IVFC as a function of fluorescence contrast (cell to background) was poorly understood. In general, three methods for fluorescent labeling of circulating cells for IVFC have been reported in the literature: 42 (1) "ex-vivo" labeling with a membrane-staining fluorescent dye such as vybrant-DiD (as in our previous work), (2) labeling of a cell line with a constitutively expressed fluorescent protein such as GFP, YFP, or mCherry, and (3) anti-body targeting of fluorophores. However, in general, methods (2) and (3) are expected to yield lower contrast than (1) due to increased autofluorescence and reduced light penetration associated with visible excitation and emission wavelengths (inherent to the physics of light propagation in biological tissue), or less efficient fluorescent probe targeting and uptake. Our initial "proofof-principle" work used method (1), which represented a relatively high-contrast imaging model. Therefore, the performance of CV-IVFC with alternate fluorophores with lower contrast imaging conditions, such as (2) and (3) above, was of significant interest.
To address this issue, in the present work, we tested CV-IVFC with a series of tissue-mimicking optical phantoms with varying levels of autofluorescence, and with calibrated cellsimulating microspheres with varying fluorescent brightness. Depending on instrument parameters, CV-IVFC allowed robust detection of microspheres with significantly lower contrast; for example, detecting at least 50% of microspheres with over two orders of magnitude lower "heterogeneous contrast" (which we define as the number of high-intensity background pixels) than our previously reported in vivo conditions. Occurrence of falsepositive detection events was found to correlate with temporal and spatial clustering of high-background pixels. As we discuss, these results are significant since they support the potential utility of CV-IVFC for a much wider range of biological models than our previous proof-of-principle studies. 2 image. The EMCCD camera was also equipped with an adjustable gain setting, which was used in fluorescence image sequences. Monochrome white light images were also obtained by backillumination with a white-light source (Digi-Slave L-Ring 3200, Edmund Optics, Barrington, New Jersey) and removal of the 710 nm emission filter. 
Computer Vision In Vivo Flow Cytometry Detection and Tracking Algorithm
Given the large illumination area, circulating cells appeared as small targets (approximately 1 to 5 pixels in size) in image sequences. The relatively large tissue autofluorescence (see Sec. 3.1 below) and camera noise (due to gain) required discrimination of moving cells from the significant background signal. Moreover, the rarity of target circulating cell populations (< 1000 cells∕mL) meant that their arrival in the imaging FOV was infrequent (about 1/min), making manual counting by a human operator tedious and error prone. To address this, we developed a computer vision algorithm to automatically detect and track circulating cells from image sequences. The details of this algorithm were previously described in detail in Ref. 40 , but are restated here briefly for completeness: The algorithm ( Fig. 2 ) was coded in MATLAB ® (Mathworks, Natick, Massachusetts) and used two main analysis steps corresponding to "detect" and "connect" operations, respectively. In Step 1, cell candidates were identified by simple pixel-by-pixel mean background subtraction and comparison to a threshold. Any pixel or groups of pixels that exceeded this threshold were assigned "1" values (zero otherwise) and were classified as cell candidates. We ranked all pixel values and chose a threshold in the range from 99.90th to 99.99th percentile of maximum, which was previously determined to work well with in vivo data. In Step 2, the dynamic behavior of cell candidates was analyzed to "connect" them into cell trajectories. This step had multiple operations. First, when a cell candidate was identified, a search was performed inside a fixed radius from the candidate in the subsequent image in the sequence. Second, search regions ("cones") corresponding to the extrapolated position of the cell candidate given its last known position, speed, and direction were searched in the subsequent 15 images in the sequence. After completion of Step 2, any residual cell candidates that were not merged into trajectories were discarded, and all remaining trajectories were saved and counted by the algorithm as circulating cells. On a 64-bit personal computer with 16 GB of RAM, analysis of a 1000 frame video took approximately 2.5 min. The performance of the algorithm was analyzed for sensitivity and false alarm rate (See Sec. 2.4.2 below).
Phantom Experiments
We developed a set of tissue (ear) mimicking optical phantoms and used a series of cell-simulating fluorescent microspheres. Our goal was to produce imaging conditions with equal or lower contrast than our previous in vivo work. Example images from these studies where vybrant-DiD labeled MM cells were tracked in mice ears in vivo are shown in Fig. 3 . 40 The variation in contrast (defined as C ¼ ½IðsÞ − IðbÞ∕½IðbÞ, where IðsÞ is the microsphere intensity and IðbÞ is the mean background intensity in an image) is evident, and ranged between 0.18 and 1.59 (average of 0.73) between experiments, which we attribute primarily to differences in cell labeling. As we quantify in detail, the phantom experiments performed here yielded conditions with significantly lower contrast, allowing us to study the performance of the CV-IVFC with increased background autofluorescence or weaker cell labeling.
Optical phantom preparation
Tissue-mimicking optical phantoms were prepared by mixing polyester resin (Castin' Craft, Environmental Technology Inc., Fields Landing, California), TiO 2 powder (Sigma Aldrich, St. Louis, Missouri), and India Ink (Higgins, Leeds, Massachusetts) to approximately match the reduced scattering coefficient (μ 0 s ¼ 15 cm −1 ) and absorption coefficient (μ a ¼ 0.1 cm −1 ) of tissue at 700 nm. 43 To replicate the approximate dimensions of the mouse ear [Figs. 4(a) and 4(b)], the resin was placed in a 20-mm diameter and a 2-mm thick mold before hardening. The phantom material alone exhibited modest autofluorescence, so we added AlexaFluor (AF)-680 dye (Life Technologies, Carlsbad, California) to simulate biological tissue autofluorescence. Likewise, sebaceous glands are a prominent feature of in vivo fluorescence images in the mouse ear and appear as bright spots [ Fig. 4(c) ] that are occasionally falsely identified as circulating cells by the CV-IVFC algorithm. To mimic this, we added 6-μm fluorescent microspheres (Peakflow Claret cytometry beads, P-24670, Life Technologies) to the phantoms. In total, three sets of phantoms (N ¼ 3 for each) were fabricated with either (1) P1; 0.4 μM AF680 and 850 microspheres per mL of resin material added, (2) P2; 0.4 μM AF680 and 1700 microspheres∕mL added, or (3) P3; 0.6 μM AF680 and 1700 microspheres∕mL added. Phantom type P2 corresponded to the approximate in vivo imaging conditions observed in our previous work, and type P3 represented a significantly elevated background fluorescence. Before hardening, a strand of Tygon tubing with a 250-μm internal diameter (TGY-010C, Small Parts, Inc., Seattle, Washington) was placed in the resin to simulate a blood vessel.
Example white light images of a phantom are shown in Figs. 4(d) and 4(e) . Two example fluorescence images are also shown from a phantom without fluorescent material added, and with fluorescent material added (phantom type P2) in Figs. 4(f) and 4(g), respectively, showing the qualitative similarity to the in vivo fluorescence image shown in Fig. 4 (c).
Fluorescent microspheres
We used calibrated fluorescent microspheres suspended in phosphate buffered saline to simulate circulating cells and flowed them through the phantoms using a microsyringe pump (70-2209, Harvard Apparatus, Holliston, Massachusetts) configured to produce a flow speed of 1.7 mm∕s in the phantom tube (typical of flow speeds observed in vivo). To simulate the effect of different cell labeling techniques, we used a set of near-infrared microspheres with varying fluorescence intensities and with similar excitation and emission spectra to, e.g., Cyanine 5.5, Alexafluor-680. These are denoted as follows for the balance of this paper: MS1 (Peakflow Claret cytometry beads, Life Technologies), MS2 (Flash Red Intensity Standard FR5, Bangs Laboratories, Inc., Fishers, Indiana) and MS3 (Flash Red Intensity Standard FR4, Bangs). As shown in Fig. 5 , these three microsphere types had fluorescence intensities equal to 200%, 62.8%, and 6.8% of the vybrant-DiD labeled MM cells that we used in our previous work. Therefore, this combination of spheres allowed us to test the performance of CV-IVFC with almost two orders of magnitude variation in fluorescence labeling.
Computer Vision In Vivo Flow Cytometry Instrument Testing

Data acquisition
We tested each of our three different phantom types with each of the three different fluorescent microspheres for a total of nine different contrast conditions. For each, microspheres suspensions of 2000 spheres∕mL were used. The EMCCD camera exposure time was 0.05 s and the gain was set in the range of 10-30 (out of camera maximum 300) to fill the dynamic range of the camera. We collected approximately 5 min of video with a minimum of 25 spheres viewed for each phantom type.
Performance metrics
Video sequences were analyzed with the CV-IVFC algorithm and cell numbers and trajectories were recorded. Performance metrics for the algorithm were then calculated as follows: (1) sensitivity ¼ TP∕ðTP þ FNÞ where TP was the true positive count matching the ground truth and FN was the false-negative counts (i.e., cells missed by the algorithm), (2) false alarm rate (FAR), which was simply the number of false-positive counts per minute. The ground truth was taken as the result of a manual count by a human operator on the same image sequence. The metrics were computed for a range of threshold percentages from 99.90 to 99.99 of the maximum pixel from Step 1 in the algorithm.
Results
Computer Vision In Vivo Flow Cytometry Performance with Varying Background Intensity
Example data generated by the CV-IVFC instrument are shown in Fig. 6 . As shown, even though contrast was poor and significant background autofluorescence (AF680 and embedded fluorescent microspheres) was present in the phantom, the algorithm was capable of robustly distinguishing moving spheres from stationary background. We systematically tested the CV-IVFC algorithm with phantoms with varying levels of background autofluorescence (phantom types P1-P3) with a single microsphere intensity (MS2). We analyzed image sequences and applied multiple detection thresholds in Step 1 of the algorithm as described in Sec. 2.2 above and in more detail in Ref. 40 . Example representative results from three individual phantoms are summarized in Fig. 7 . As indicated (and consistent with our previous work), the use of a lower threshold increased overall detection sensitivity [ Fig. 7(a) ] at the cost of increased FAR [ Fig. 7(b) ], whereas the use of a higher threshold reduced both parameters. In general, adjustment of this threshold allowed us to trade-off sensitivity and FAR with the system. 
Computer Vision In Vivo Flow Cytometry Instrument Performance with Varying
Microsphere Intensity
Next, we tested a single phantom (P2) with three different microsphere types with decreasing fluorescence intensities (MS1-MS3). Again, we computed sensitivity and FAR for a series of threshold values, and the data are summarized in Fig. 9 . Generally, this followed the same trend as above, in that increasing the detection threshold resulted in lower sensitivity [ Fig. 9(a) ] and lower FAR [ Fig. 9(b) ]. We also note that, in general, shorter trajectories were extracted by the CV-IVFC algorithm in lower contrast conditions. Specifically, the average microsphere track lengths were 2.14, 1.42, and 0.82 mm for MS1, MS2, and MS3 types, respectively (see Fig. 10 ). Although circulating microspheres were visible for only brief periods in low contrast conditions, CV-IVFC was capable of robustly detecting them.
Computer Vision In Vivo Flow Cytometry Instrument Performance Summary: All Conditions
The overall performance of the CV-IVFC algorithm for the phantom and microsphere tests performed here is summarized in Fig. 11 . We first considered the overall sensitivity of the algorithm for all 27 combinations (3 microsphere intensities × 9 phantoms) as a function of the image contrast. These data are shown in Fig. 11(a) . (Here, we selected a threshold of the 99.95th percentile for the algorithm in Step 2, although this curve could be re-generated for any other threshold). All phantoms and microsphere combinations that we tested are shown, where the triangle markers correspond to MS1, squares to MS2, and circles to MS3. As indicated, although three sets of nominally identical phantoms were fabricated (P1-P3), significant inter-phantom variability was observed. For this reason, we plotted all individual data points (rather than means and standard deviations). As shown, the range of average contrasts (C) for different phantom-microsphere combinations was between 0.23 and 1.54, although the contrast of individual microspheres was as low as 0.06. For comparison, the range obtained from our earlier in vivo experiments is indicated in red [ Fig. 3 and Ref. 40] , where an average contrast of 0.73 was observed. By inspection, C was a poor predictor of algorithm performance for low contrast phantom-microsphere combinations (i.e., when C < 0.5), which as we have noted was our primary interest in this study. Review of our data suggested that the algorithm yielded highest tracking sensitivity when the background autofluorescence was relatively homogenous and could be effectively removed by subtraction. Therefore, as an alternative metric, we next considered the heterogeneity of the background intensity, which we defined as the number of "bright pixels" per frame in the image sequence [ Fig. 11(b) ]. Here, "bright pixels" were defined as the number of pixels per image after background subtraction that exceeded the mean intensity of a microsphere. In other words, these are the number of pixels where the noise on the pixel was comparable to the intensity of a microsphere. For the phantom experiments, a range of 0.2 to 518.3 bright pixels per image were observed, whereas on average 2.86 bright pixels per image was observed in our previous in vivo data. By inspection, the in vivo data generally agree with the phantom data, suggesting that our phantom-microsphere model mimicked in vivo imaging conditions well. Somewhat surprisingly [as shown in Fig. 11(c) ], the number of bright pixels correlated only weakly with the FAR, since the CV-IVFC algorithm (
Step 2) was efficient at rejecting bright pixels that were physically well separated. Further analysis revealed that a more complex quantity--the number of "bright pixel clusters" per minute--correlated well with FAR as shown in Fig. 11(d) . Here, "bright pixel clusters" were defined as the number of occurrences for which two bright pixels were detected in subsequent image frames within a fixed radius (6 pixels). Analysis of our data indicated that, in general, these led to erroneous formation of microsphere trajectories. As above, our previous in vivo data were coplotted with the phantom data showing good general agreement. The implications of these results are discussed below.
Discussion and Conclusion
We recently developed and validated CV-IVFC as a new technology for detection, enumeration, and tracking of rare circulating cells in small animals in vivo. The major advantage of CV-IVFC compared to previous IVFC designs is the relatively large circulating blood volume that is sampled, leading to improved detection of low-abundance cells. We previously showed that this instrument was capable of detecting circulating cells in the range of 20 cells∕mL. The purpose of the studies performed here was to characterize CV-IVFC under conditions of low imaging contrast compared to our previous in vivo studies. The data in Fig. 11 summarize the effects of reduction in contrast from either mechanism. In combination, Figs. 11(a) and 11(b) show the effect of loss of contrast (homogenous and heterogeneous) on detection sensitivity, and illustrate that CV-IVFC can effectively detect and track fluorescent targets with significantly lower contrast than in our previous in vivo studies. To quantify this, we considered the heterogeneous contrast data shown in Fig. 11(b) . Although the parent function for these data is unknown, for comparison purposes we fit a linear function [dotted line on Fig. 11(b) ; note that this appears as a curve due to the logarithmic x-axis]. This fit implies that CV-IVFC would retain 80% detection sensitivity for the case corresponding to 109 bright pixels per image, which is equivalent to 38 times lower contrast versus our in vivo studies, where 2.86 bright pixels per image were observed on average. Likewise, 50% of microspheres would still be detected for the case of 457 bright pixels per image, corresponding to 159 times lower contrast. In practice, this reduction in contrast could come from either less-efficient fluorophore cell labeling, lower fluorescence quantum yield, or increase in background autofluorescence. This greatly increases the potential utility of CV-IVFC since it can be used with a wide range of fluorophores and labeling techniques. Absolute quantification of the mean equivalent soluble fluorochrome units for the microspheres was not available from the manufacturer, but comparison with our previous work and the literature values suggests that the intensity of the MS2 type would be comparable to a "typical" well-labeled cell. For example, comparison of extinction coefficient and emission quantum yield data suggests that cells labeled with the Turbo-FP650 red fluorescent protein (RFP; Evrogen, Moscow, Russia) [44] [45] [46] would be about three times less-brightly labeled than with vybrant-DiD. Likewise, the use of a green fluorophore would reduce the contrast by approximately a factor of 10 due to increased autofluorescence, [47] [48] [49] [50] which (according to the analysis here) would not significantly degrade CV-IVFC sensitivity.
As we have noted, the relationship between FAR and bright pixels was more complex, since FAR was found to correlate with the number of "cell clusters" relating to both the temporal and spatial distribution of bright targets. In practice, this suggests that relatively high background autofluorescence can be tolerated by the algorithm without significant increase in FAR provided that bright pixels are physically separated in the image. As noted above, sensitivity and FAR can be traded-off by adjusting the "threshold" parameter in Step 1. In CV-IVFC, false alarms can be easily discounted by a human operator reviewing the original image sequence. Because the algorithm reports the time of detection in the image sequence, this is significantly more time efficient than manually counting cells with long (30 min or more) data acquisitions. Therefore, in practice, higher FAR is generally preferable to lower sensitivity in CV-IVFC.
We also note that the results shown here pertain specifically to our existing CV-IVFC instrument and algorithms and do not represent a technical limit of the technique. Improvement of the CV-IVFC tracking algorithm is the subject of ongoing work in our lab; we are currently pursuing a number of alternative strategies, for example, by jointly solving the "detect and connect" problem, as opposed to our current two-step process. Likewise, we have noted that stationary but distributed bright regions (such as sebaceous glands) appearing in multiple images frequently trigger false positives in the algorithm. As such, we are studying methods to automatically detect such regions and reject them as cell candidates. Therefore, we expect that a better CV-IVFC performance may be achieved in the future.
